2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative D Aletaha, T Neogi, AJ Silman, J Funovits, DT Felson, CO Bingham III, ... Arthritis & rheumatism 62 (9), 2569-2581, 2010 | 14813 | 2010 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ... Annals of the rheumatic diseases 76 (6), 960-977, 2017 | 5766 | 2017 |
Treating rheumatoid arthritis to target: recommendations of an international task force JS Smolen, D Aletaha, JWJ Bijlsma, FC Breedveld, D Boumpas, ... Annals of the rheumatic diseases 69 (4), 631-637, 2010 | 2917 | 2010 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update JS Smolen, RBM Landewé, JWJ Bijlsma, GR Burmester, M Dougados, ... Annals of the rheumatic diseases 79 (6), 685-699, 2020 | 2654 | 2020 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs JS Smolen, R Landewé, FC Breedveld, M Dougados, P Emery, ... Annals of the rheumatic diseases 69 (6), 964-975, 2010 | 2394 | 2010 |
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials DT Felson, JS Smolen, G Wells, B Zhang, LHD Van Tuyl, J Funovits, ... Arthritis & Rheumatism 63 (3), 573-586, 2011 | 1880 | 2011 |
Diagnosis and management of rheumatoid arthritis: a review D Aletaha, JS Smolen Jama 320 (13), 1360-1372, 2018 | 1858 | 2018 |
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force JS Smolen, FC Breedveld, GR Burmester, V Bykerk, M Dougados, ... Annals of the rheumatic diseases 75 (1), 3-15, 2016 | 1665 | 2016 |
New therapies for treatment of rheumatoid arthritis JS Smolen, D Aletaha, M Koeller, MH Weisman, P Emery The lancet 370 (9602), 1861-1874, 2007 | 1366 | 2007 |
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score D Aletaha, VPK Nell, T Stamm, M Uffmann, S Pflugbeil, K Machold, ... Arthritis research & therapy 7, 1-11, 2005 | 1205 | 2005 |
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update L Gossec, JS Smolen, S Ramiro, M De Wit, M Cutolo, M Dougados, ... Annals of the rheumatic diseases 75 (3), 499-510, 2016 | 1152 | 2016 |
The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis D Aletaha, J Smolen Clinical and experimental rheumatology 23 (5), S100, 2005 | 1106 | 2005 |
EULAR recommendations for the management of Behçet disease G Hatemi, A Silman, D Bang, B Bodaghi, AM Chamberlain, A Gul, ... Annals of the rheumatic diseases 67 (12), 1656-1662, 2008 | 1001 | 2008 |
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update L Gossec, X Baraliakos, A Kerschbaumer, M de Wit, I McInnes, ... Annals of the rheumatic diseases 79 (6), 700-712, 2020 | 937 | 2020 |
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in … G Wells, JC Becker, J Teng, M Dougados, M Schiff, J Smolen, D Aletaha, ... Annals of the rheumatic diseases 68 (6), 954-960, 2009 | 918 | 2009 |
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force JS Smolen, M Schöls, J Braun, M Dougados, O FitzGerald, DD Gladman, ... Annals of the rheumatic diseases 77 (1), 3-17, 2018 | 717 | 2018 |
Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states D Aletaha, MM Ward, KP Machold, VPK Nell, T Stamm, JS Smolen Arthritis & Rheumatism 52 (9), 2625-2636, 2005 | 698 | 2005 |
2016 update of the EULAR recommendations for the management of early arthritis B Combe, R Landewe, CI Daien, C Hua, D Aletaha, JM Álvaro-Gracia, ... Annals of the rheumatic diseases 76 (6), 948-959, 2017 | 665 | 2017 |
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ... Annals of the rheumatic diseases 71 (1), 4-12, 2012 | 593 | 2012 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update JS Smolen, RBM Landewé, SA Bergstra, A Kerschbaumer, A Sepriano, ... Annals of the rheumatic diseases 82 (1), 3-18, 2023 | 581 | 2023 |